Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages

scientific article published on January 2007

Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1177/0961203307084170
P698PubMed publication ID18042586

P50authorYehuda ShoenfeldQ1515807
Eiji MatsuuraQ73476759
P2093author name stringKobayashi K
Yasuda T
Ueno T
Tsutsumi A
de Groot PG
Kuwana M
Tada K
Itabe H
Liu PH
P2860cites workBinding of beta 2-glycoprotein I to anionic phospholipids facilitates processing and presentation of a cryptic epitope that activates pathogenic autoreactive T cellsQ24307173
Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)Q24558202
Adhesion mechanism of human beta(2)-glycoprotein I to phospholipids based on its crystal structure.Q27619832
Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunityQ28344371
Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and manQ28359675
THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUMQ29391553
Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein EQ29615236
Antigenic structures recognized by anti-beta2-glycoprotein I auto-antibodiesQ33225081
i.v.IG for autoimmune, fibrosis, and malignant conditions: our experience with 200 patientsQ33360957
Intravenous immunoglobulins control scleromyxoedemaQ34486310
Immunomodulatory action of intravenous immunoglobulin.Q35013334
SLE, atherosclerosis and cardiovascular diseaseQ36135534
IVIg therapy in autoimmunity and related disorders: our experience with a large cohort of patientsQ36205447
Accelerated atherosclerosis in autoimmune rheumatic diseasesQ36318870
Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosisQ36514385
Oxidized phosphatidylcholines that modify proteins. Analysis by monoclonal antibody against oxidized low density lipoproteinQ36838426
Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasmaQ37358413
Normal polyspecific immunoglobulin G (IVIg) in the treatment of autoimmune diseasesQ40738864
Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surfaceQ42084495
Coronary atherosclerosis and oxidative stress as reflected by autoantibodies against oxidized low-density lipoprotein and oxysterolsQ43545513
Correlation of antiphospholipid antibody recognition with the structure of synthetic oxidized phospholipids. Importance of Schiff base formation and aldol condensationQ43823942
Omega-carboxyl variants of 7-ketocholesteryl esters are ligands for beta(2)-glycoprotein I and mediate antibody-dependent uptake of oxidized LDL by macrophagesQ44138798
Circulating oxidized LDL forms complexes with beta2-glycoprotein I: implication as an atherogenic autoantigenQ44300088
Immunoglobulin treatment suppresses atherosclerosis in apolipoprotein E-deficient mice via the Fc portionQ44513069
Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL.Q46095021
Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease.Q50847890
Antibodies to adult human endothelial cells cross-react with oxidized low-density lipoprotein and beta 2-glycoprotein I (beta 2-GPI) in systemic lupus erythematosusQ58190397
P433issue12
P921main subjectantibodyQ79460
P304page(s)929-938
P577publication date2007-01-01
P1433published inLupusQ6704846
P1476titleDistinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages
P478volume16

Reverse relations

cites work (P2860)
Q37143021Accelerated atherosclerosis is independent of feeding high fat diet in systemic lupus erythematosus-susceptible LDLr(-/-) mice
Q37190468Antigen-induced immunomodulation in the pathogenesis of atherosclerosis.
Q37378106Atherosclerosis in autoimmune diseases
Q37606350Autoimmunity, infectious immunity, and atherosclerosis
Q37428743Management of cardiovascular disease risk in chronic inflammatory disorders
Q37318786Oxidative modification of LDL: its pathological role in atherosclerosis
Q36671159Pathophysiological mechanisms in antiphospholipid syndrome
Q37721597Pathophysiology of beta2-glycoprotein I in antiphospholipid syndrome
Q37328097Pentraxins, anti-pentraxin antibodies, and atherosclerosis
Q58802965Pro‑atherogenic activation of A7r5 cells induced by the oxLDL/β2GPI/anti‑β2GPI complex
Q28553042Simvastatin Efficiently Lowers Small LDL-IgG Immune Complex Levels: A Therapeutic Quality beyond the Lipid-Lowering Effect
Q37173369Targeting oxidized LDL improves insulin sensitivity and immune cell function in obese Rhesus macaques.
Q34644753The inhibitory FcγRIIb modulates the inflammatory response and influences atherosclerosis in male apoE−/− mice
Q33575750The lupus susceptibility locus Sle3 is not sufficient to accelerate atherosclerosis in lupus-susceptible low density lipoprotein receptor-deficient mice.

Search more.